Insomnia, a common symptom throughout the world, is characterised by difficulty initiating or
maintaining sleep or non‐restorative sleep and is associated with significant morbidity. A …

Insomnia is a commonly encountered condition in clinical practice. The prevalence of self-
reported poor sleep increases with age and is more common in women. There are clear …

Several different types of medications are currently available for the treatment of insomnia.
These agents include:(1) a group approved by the US Food and Drug Administration (FDA) …

Background. Despite the high prevalence and the high burden associated with chronic
insomnia, it remains largely unrecognized and often inadequately treated by physicians …

INSOMNIA, OR THE DISSATISFACTION WITH THE QUANTITY, quality or timing of sleep, is
a common complaint. Because the definition of" normal" sleep is not well established, the …

Insomnia is a highly prevalent condition associated with significant morbidity, reduction in
quality of life, and increase in healthcare costs, and is a risk factor for multiple physical and …

Chronic insomnia afflicts up to 10% of the population in Western industrialized countries. It is
characterized by delayed sleep onset, problems in maintaining sleep, early morning …

For many years practitioners have had limited data from double-blind, placebo-controlled
studies to guide the types of decision-making needed to optimally manage patients with …

The first source on insomnia treatment since the advancement of newer drug options and
cognitive behavioral therapies, Insomnia: Diagnosis and Treatment presents a …

Insomnia is the most common sleep disorder in the industrialized world. A variety of
precipitating events have been identified, but when it becomes a persistent problem …